These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 21925231)

  • 1. 5-HT2A/C receptors mediate the antipsychotic-like effects of alstonine.
    Linck VM; Bessa MM; Herrmann AP; Iwu MM; Okunji CO; Elisabetsky E
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):29-33. PubMed ID: 21925231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putative antipsychotic alstonine reverses social interaction withdrawal in mice.
    de Moura Linck V; Herrmann AP; Goerck GC; Iwu MM; Okunji CO; Leal MB; Elisabetsky E
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1449-52. PubMed ID: 18539376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic properties of the antipsychotic alkaloid alstonine.
    Costa-Campos L; Dassoler SC; Rigo AP; Iwu M; Elisabetsky E
    Pharmacol Biochem Behav; 2004 Mar; 77(3):481-9. PubMed ID: 15006458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the putative antipsychotic alstonine on glutamate uptake in acute hippocampal slices.
    Herrmann AP; Lunardi P; Pilz LK; Tramontina AC; Linck VM; Okunji CO; Gonçalves CA; Elisabetsky E
    Neurochem Int; 2012 Dec; 61(7):1144-50. PubMed ID: 22940693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic profile of alstonine: ethnopharmacology of a traditional Nigerian botanical remedy.
    Costa-Campos L; Elisabetsky E; Lara DR; Carlson TJ; King SR; Ubillas R; Nunes DS; Iwu MM; Nkemjika CO; Ozioko A; Agwu CO
    An Acad Bras Cienc; 1999; 71(2):189-201. PubMed ID: 10412490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Original mechanisms of antipsychotic action by the indole alkaloid alstonine (Picralima nitida).
    Linck VM; Ganzella M; Herrmann AP; Okunji CO; Souza DO; Antonelli MC; Elisabetsky E
    Phytomedicine; 2015 Jan; 22(1):52-5. PubMed ID: 25636871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of pro-convulsant activity of the antipsychotic alkaloid alstonine.
    Costa-Campos L; Iwu M; Elisabetsky E
    J Ethnopharmacol; 2004 Aug; 93(2-3):307-10. PubMed ID: 15234769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio).
    Seibt KJ; Piato AL; da Luz Oliveira R; Capiotti KM; Vianna MR; Bonan CD
    Behav Brain Res; 2011 Oct; 224(1):135-9. PubMed ID: 21669233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mGlu2 in the 5-HT
    Hideshima KS; Hojati A; Saunders JM; On DM; de la Fuente Revenga M; Shin JM; Sánchez-González A; Dunn CM; Pais AB; Pais AC; Miles MF; Wolstenholme JT; González-Maeso J
    Psychopharmacology (Berl); 2018 Nov; 235(11):3149-3165. PubMed ID: 30209534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
    Ishiyama T; Tokuda K; Ishibashi T; Ito A; Toma S; Ohno Y
    Eur J Pharmacol; 2007 Oct; 572(2-3):160-70. PubMed ID: 17662268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic-like profile of alstonine.
    Costa-Campos L; Lara DR; Nunes DS; Elisabetsky E
    Pharmacol Biochem Behav; 1998 May; 60(1):133-41. PubMed ID: 9610935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.
    Manahan-Vaughan D; von Haebler D; Winter C; Juckel G; Heinemann U
    Hippocampus; 2008; 18(2):125-34. PubMed ID: 17924525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M
    Gould RW; Grannan MD; Gunter BW; Ball J; Bubser M; Bridges TM; Wess J; Wood MW; Brandon NJ; Duggan ME; Niswender CM; Lindsley CW; Conn PJ; Jones CK
    Neuropharmacology; 2018 Jan; 128():492-502. PubMed ID: 28729220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
    Marquis KL; Sabb AL; Logue SF; Brennan JA; Piesla MJ; Comery TA; Grauer SM; Ashby CR; Nguyen HQ; Dawson LA; Barrett JE; Stack G; Meltzer HY; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2007 Jan; 320(1):486-96. PubMed ID: 17038512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal models of schizophrenia using different laboratory mouse strains].
    Wu JH; Zou H; Yu J; Zhou XD; Xie QL; Jin ML
    Sheng Li Xue Bao; 2003 Aug; 55(4):381-7. PubMed ID: 12937815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.
    Horisawa T; Ishibashi T; Nishikawa H; Enomoto T; Toma S; Ishiyama T; Taiji M
    Behav Brain Res; 2011 Jun; 220(1):83-90. PubMed ID: 21277905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of CA1 5HT4 receptors in MK801-induced amnesia and hyperlocomotion.
    Nasehi M; Tabatabaie M; Khakpai F; Zarrindast MR
    Neurosci Lett; 2015 Feb; 587():73-8. PubMed ID: 25524640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts.
    Fadda P; Robinson L; Fratta W; Pertwee RG; Riedel G
    Behav Brain Res; 2006 Apr; 168(2):307-11. PubMed ID: 16406104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
    Gravius A; Laszy J; Pietraszek M; Sághy K; Nagel J; Chambon C; Wegener N; Valastro B; Danysz W; Gyertyán I
    Behav Pharmacol; 2011 Apr; 22(2):122-35. PubMed ID: 21301322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.